Wellgistics Health, Inc. (WGRX) — Current Report

AI-Powered SEC Filing Analysis

Latest Current Report Filed: 2026-04-09

Key Insights

Wellgistics Health, Inc. has terminated a previously disclosed settlement agreement with Silverback Capital Inc. that involved the issuance of shares of the company's common stock.
The termination of the settlement agreement will eliminate potential future dilution for Wellgistics Health, Inc. shareholders.
The company stated that it is pursuing alternative strategic and financing initiatives, which could signal a shift in the company's direction or a focus on strengthening its financial position.

Want the newest filings?

This analysis covers the filing from 2026-04-09. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-04-07

Wellgistics Health, Inc. has entered into a $1.25 million note purchase agreement with investors, providing additional capital that could be used to fund the company's growth and operations.
The notes have a 20% original issue discount and 0% interest rate, except in the event of default, suggesting favorable terms for the company.
The agreement includes a provision allowing the investors to participate in future offerings, potentially providing a path for additional funding and investor alignment.

Filed: 2026-02-13

Wellgistics Health, Inc. entered into a settlement agreement with Silverback Capital Corporation to issue shares of its common stock in satisfaction of over $10.7 million in liabilities.
The company obtained court approval for the settlement agreement, which allows the shares to be issued under a Section 3(a)(10) exemption from securities registration.
The settlement includes the issuance of additional shares as a settlement fee and to cover legal expenses, providing further dilution to existing shareholders.

Filed: 2026-01-20

Wellgistics Health, Inc. (WGRX) has secured $6.5 million in convertible note financing, providing additional capital to fund operations and growth.
The notes contain a 20% original issue discount and have a six-month maturity, indicating a near-term need for additional financing or a qualified equity raise.
The notes are secured by the company's assets and intellectual property, and are guaranteed by a subsidiary, providing lenders with additional protection.

Filed: 2026-01-08

Wellgistics Health, Inc. has raised $2.5 million through a private convertible note offering, providing capital to fund its operations and growth.
The convertible notes can be converted into equity in the company's next qualified financing round, giving investors potential upside if the company raises additional capital.
The company has agreed to certain restrictions on incurring additional debt or granting new liens, which could help protect the interests of the note holders.

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.